Fonte: Basic & Clinical Pharmacology & Toxicology. Unidade: FCF
Assuntos: POLIMORFISMO, BIOMARCADORES
ABNT
LUCHESSI, André Ducati et al. ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy. Basic & Clinical Pharmacology & Toxicology, v. 120 p. 466-474, 2017Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12703. Acesso em: 21 ago. 2024.APA
Luchessi, A. D., Concheiro, M., Germano, J. de F., Silbiger, V. N., Bortolin, R. H., Cruz, A., et al. (2017). ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy. Basic & Clinical Pharmacology & Toxicology, 120 p. 466-474. doi:10.1111/bcpt.12703NLM
Luchessi AD, Concheiro M, Germano J de F, Silbiger VN, Bortolin RH, Cruz A, Quintela O, Brion M, Carracedo A, Iñiguez A, Bravo M, Rivadulla ML, Hirata RDC, Sousa AG de MR, Hirata MH. ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy [Internet]. Basic & Clinical Pharmacology & Toxicology. 2017 ; 120 p. 466-474[citado 2024 ago. 21 ] Available from: https://doi.org/10.1111/bcpt.12703Vancouver
Luchessi AD, Concheiro M, Germano J de F, Silbiger VN, Bortolin RH, Cruz A, Quintela O, Brion M, Carracedo A, Iñiguez A, Bravo M, Rivadulla ML, Hirata RDC, Sousa AG de MR, Hirata MH. ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy [Internet]. Basic & Clinical Pharmacology & Toxicology. 2017 ; 120 p. 466-474[citado 2024 ago. 21 ] Available from: https://doi.org/10.1111/bcpt.12703